Digital Biomarkers Market 2032
Digital biomarkers market report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics.
Growth of the global digital biomarkers market size is majorly driven by high presence of market players who manufacture digital biomarkers, and technological advancements for development.— Allied Market Research
WILMINGTON, DELAWARE, UNITED STATES, June 26, 2024 /
EINPresswire.com/ -- Allied Market Research published a report titled, "
Digital Biomarkers Market by Type (Wearable, Mobile Application, Software, and Others), Application (Cardiovascular Disease, Sleep and Movement Disease, Neurological Disorders, and Others), and End User (Healthcare Companies, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032." According to the report, the global digital biomarkers market was valued at $2.1 billion in 2022 and is projected to reach $14.7 billion by 2032, registering a CAGR of 21.3% from 2023 to 2032.
Digital biomarkers are physiological, behavioral, or clinical markers that may be measured and studied using digital technology. Digital biomarkers market are further subdivided into active and passive biomarkers. Active digital biomarkers are gathered during prompted actions. They are captured and generated by smartphones, tablets, and other devices when a person interacts with the device in response to an active prompt.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ
https://www.alliedmarketresearch.com/purchase-enquiry/132906
By type, the digital biomarkers market size is classified into wearable, mobile application, software, and others (sensor, card and implantable). The wearable segment is expected to be the fastest growing segment during the forecast period owing to rise in number of product approvals for wearable and rise in adoption of wearable digital biomarker by population.
By application, the digital biomarkers market size is classified into cardiovascular disease, sleep and movement disease, neurological disorders, and others (respiratory diseases, diabetes, psychiatric and musculoskeletal disorders). The cardiovascular disease segment is projected to be the fastest growing segment during the forecast period owing to rise in prevalence of cardiovascular diseases and high in number of product provision of digital biomarkers for cardiovascular disease monitoring and diagnosis.
By clinical practice, the digital biomarkers market share is classified into monitoring, diagnostic and prognostic. The monitoring segment is projected to be the fastest growing segment during the forecast period owing to rise in adoption of digital biomarkers for monitoring purpose and hogh presence of manufacturers who manufactures digital biomarkers for monitoring.
By end user, the digital biomarkers market analysis is classified into healthcare companies, hospitals, and others (payers and patients). The healthcare companies segment is projected to be the fastest growing segment during the forecast period owing to rise in number of clinical trials and research activities using digital biomarkers by healthcare companies.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
Koneksahealth, ActiGraph LLC, Verily Life Sciences LLC, Empatica, Brainomix, Clario, Feel Therapeutics, Sonde Health, Inc., Amgen Inc., AliveCor
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ
https://www.alliedmarketresearch.com/request-sample/132906
๐๐ก๐๐ญ ๐ข๐ฌ ๐ญ๐ก๐ ๐๐ฆ๐ฉ๐๐๐ญ ๐จ๐ ๐๐๐๐๐ฌ๐ฌ๐ข๐จ๐ง ๐๐๐๐ ๐จ๐ง ๐๐ข๐ ๐ข๐ญ๐๐ฅ ๐๐ข๐จ๐ฆ๐๐ซ๐ค๐๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ?
The 2023 recession has negatively impacted the global digital biomarkers market, resulting in hiring freezes, budget cuts, or reductions in the workforce. These constraints are projected to limit the availability of skilled personnel to deploy and manage the digital healthcare system.
However, the global digital biomarkers market is expected to recover from the negative impact of the recession as demand for new treatment options for chronic diseases rises.
๐๐ก๐ ๐๐๐ซ๐๐ข๐จ๐ฏ๐๐ฌ๐๐ฎ๐ฅ๐๐ซ ๐๐ข๐ฌ๐๐๐ฌ๐๐ฌ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ ๐ญ๐จ ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง ๐ข๐ญ๐ฌ ๐ฅ๐๐๐ ๐ฉ๐จ๐ฌ๐ข๐ญ๐ข๐จ๐ง ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก๐จ๐ฎ๐ญ ๐ญ๐ก๐ ๐๐จ๐ซ๐๐๐๐ฌ๐ญ ๐ฉ๐๐ซ๐ข๐จ๐-
Based on application, the cardiovascular diseases segment held the highest market share in 2022, accounting for nearly two-fifths of the global digital biomarkers market revenue, and is estimated to maintain its lead position throughout the forecast period. Due to the rise in the prevalence of cardiovascular diseases and increased awareness among the public regarding digital biomarkers for cardiac diseases. However, the diabetes segment is projected to manifest a significant CAGR of 22.3% from 2023 to 2032. Due to the rising prevalence of diabetes.
๐๐๐ง๐ญ ๐ญ๐จ ๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐จ๐ซ๐, ๐๐จ๐ง๐ง๐๐๐ญ ๐ญ๐จ ๐จ๐ฎ๐ซ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ญ-
https://www.alliedmarketresearch.com/connect-to-analyst/132906
๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐๐:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on โStrategic Developmentsโ registered by leading players of the market
๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐ ๐ญ๐จ ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง ๐ข๐ญ๐ฌ ๐๐จ๐ฆ๐ข๐ง๐๐ง๐๐ ๐๐ฒ ๐๐๐๐-
Based on region, North America held the highest market share in 2022, holding nearly half of the global digital biomarkers market revenue, and is likely to dominate the market during the forecast period. The growth is attributed to the high presence of digital biomarker manufacturers in North America and the rising prevalence of chronic disease. However, the Asia-Pacific region is expected to witness the fastest CAGR of 22.3% from 2023 to 2032. Owing to the rising number of geriatric populations, it is more susceptible to chronic diseases, and an increase in awareness among people regarding digital biomarkers.
๐๐๐จ๐ฎ๐ญ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of the domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter